tiprankstipranks
Advertisement
Advertisement

BFRI Stock Latest News

Biofrontera Shareholders Approve Director Elections and Equity Plan
Company AnnouncementsBiofrontera Shareholders Approve Director Elections and Equity Plan
9d ago
8K
BFRI
Biofrontera Earnings Call Highlights Growth And Risks
PremiumCompany Announcements
Biofrontera Earnings Call Highlights Growth And Risks
24d ago
BFRI
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
1M ago
AMT
BAP
Biofrontera downgraded to Speculative Buy from Buy at Benchmark
PremiumThe Fly
Biofrontera downgraded to Speculative Buy from Buy at Benchmark
1M ago
BFRI
Is BFRI a Buy, Before Earnings?
PremiumPre-Earnings
Is BFRI a Buy, Before Earnings?
2M ago
BFRI
Biofrontera Earnings Call: Profits Rise, Risks Remain
PremiumCompany AnnouncementsBiofrontera Earnings Call: Profits Rise, Risks Remain
3M ago
BFRI
Biofrontera reports Q4 revenue $17.1M vs. $12.6M last year
Premium
The Fly
Biofrontera reports Q4 revenue $17.1M vs. $12.6M last year
3M ago
BFRI
Biofrontera, Inc. (BFRI) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Biofrontera, Inc. (BFRI) Q4 Earnings Cheat Sheet
3M ago
BFRI
Biofrontera Reports Positive Phase 2b Acne Trial Results
PremiumCompany Announcements
Biofrontera Reports Positive Phase 2b Acne Trial Results
4M ago
8K
BFRI
Biofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris
PremiumThe Fly
Biofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris
4M ago
BFRI
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute
PremiumCompany Announcements
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute
4M ago
8K
BFRI
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims
PremiumThe Fly
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims
4M ago
BFRI
Biofrontera announces database lock of Phase 1 PK study of Ameluz
PremiumThe FlyBiofrontera announces database lock of Phase 1 PK study of Ameluz
4M ago
BFRI
Biofrontera announces FDA acceptance of sNDA for Ameluz PDT
Premium
The Fly
Biofrontera announces FDA acceptance of sNDA for Ameluz PDT
5M ago
BFRI
Biofrontera Reports Positive Phase 3 Ameluz PDT Results
Premium
Company Announcements
Biofrontera Reports Positive Phase 3 Ameluz PDT Results
5M ago
8K
BFRI
Biofrontera announces positive Phase 3 results for Ameluz PDT
PremiumThe Fly
Biofrontera announces positive Phase 3 results for Ameluz PDT
5M ago
BFRI
Biofrontera reports preliminary Q4 revenue $17M-$17.5M
PremiumThe Fly
Biofrontera reports preliminary Q4 revenue $17M-$17.5M
5M ago
BFRI
Biofrontera announces data base locks for two clinical studies
PremiumThe Fly
Biofrontera announces data base locks for two clinical studies
6M ago
BFRI
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance
PremiumCompany Announcements
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance
6M ago
8K
BFRI
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval
PremiumThe FlyBiofrontera completes transfer of Ameluz, RhodoLED FDA approval
6M ago
BFRI
Biofrontera Inc. files to sell 4M shares of common stock for holders
Premium
The Fly
Biofrontera Inc. files to sell 4M shares of common stock for holders
7M ago
BFRI
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel
Premium
The Fly
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel
7M ago
BFRI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >